Biontech Se ADR (BNTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 06-2026 | 03-2026 | 12-2025 | 09-2025 | 06-2025 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,658,940 | -664,904 | -1,188,875 | -962,472 | -962,763 |
| Depreciation Amortization | 450,430 | 141,970 | 433,100 | 254,820 | 106,482 |
| Accounts receivable | 926,788 | 504,559 | 1,226,098 | 1,172,056 | 137,359 |
| Accounts payable and accrued liabilities | -171,149 | -435,272 | -818,907 | -349,735 | -64,025 |
| Other Working Capital | 767,498 | 77,481 | 608,467 | 894,442 | 137,586 |
| Other Operating Activity | -791,915 | -116,572 | 256,036 | -837,867 | -74,583 |
| Operating Cash Flow | $-477,288 | $-492,738 | $515,918 | $171,244 | $-719,944 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | N/A | N/A | N/A | -8,236,888 | N/A |
| PPE Investments | -123,711 | -64,606 | -193,017 | -126,241 | -85,140 |
| Net Acquisitions | N/A | N/A | 210,780 | -91,759 | -89,113 |
| Purchase Of Investment | -4,192,813 | -1,814,354 | -12,923,420 | N/A | -4,742,525 |
| Sale Of Investment | 7,308,616 | 5,007,088 | 10,762,100 | 9,427,529 | 6,908,714 |
| Purchase Sale Intangibles | -26,626 | -25,866 | -649,311 | -672,118 | -649,675 |
| Other Investing Activity | -26,626 | -25,866 | -649,304 | -672,117 | -649,676 |
| Investing Cash Flow | $2,965,466 | $3,102,262 | $-2,792,861 | $300,524 | $1,342,260 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 88,598 | 44,943 | 7,580 | N/A | N/A |
| Debt Repayment | -6,860 | -117 | -20,365 | -10,988 | -9,309 |
| Common Stock Repurchased | -150,221 | N/A | N/A | N/A | N/A |
| Other Financing Activity | -26,975 | -13,928 | -47,066 | -34,132 | -21,455 |
| Financing Cash Flow | $-95,458 | $30,899 | $-59,851 | $-45,120 | $-30,764 |
| Exchange Rate Effect | -7,790 | -3,979 | -30,548 | -33,197 | -7,833 |
| Beginning Cash Position | 8,924,188 | 8,983,288 | 11,044,610 | 11,410,680 | 11,081,710 |
| End Cash Position | 11,325,860 | 11,633,070 | 8,683,947 | 11,797,590 | 11,657,940 |
| Net Cash Flow | $2,401,673 | $2,649,786 | $-2,360,666 | $386,906 | $576,228 |
| Free Cash Flow | |||||
| Operating Cash Flow | -477,288 | -492,738 | 515,918 | 171,244 | -719,944 |
| Capital Expenditure | -129,525 | -66,479 | -198,108 | -130,800 | -86,275 |
| Free Cash Flow | -606,813 | -559,217 | 317,810 | 40,444 | -806,219 |